Recently, Yulai Liang at al. showed that PD-L1 specific affinity peptides (PPL-C) exhibited antitumor effect in colon cancer by inhibiting PD-1/PD-L1 interaction. This evidence concerns the gene CD274 and colonic neoplasm.